The 23andMe experience for participants.
Useful insight into their own genome.
Every participant will receive 60+ personalized genetic reports covering health, traits and ancestry.
Carrier Status reports*35+ Reports
If the participant is starting a family, they can find out if they are a carrier for an inherited condition.
Sickle Cell Anemia
Hereditary Hearing Loss
Ancestry reports3 Reports
What DNA says about a participant’s family history.
Maternal & Paternal Lineage
Wellness reports6 Reports
Helping participants make more informed choices about diet and exercise.
Alcohol Flush Reaction
Traits reports19+ Reports
What makes each participant unique, from food preferences to physical features.
Sweet vs. Salty
23andMe is the first and only company to offer a direct-to-consumer genetic test that includes reports that meet FDA standards.
All carrier status reports
|ARSACS||SACS||1 Variant||French Canadian|
|Agenesis of the Corpus Callosum with Peripheral Neuropathy||SLC12A6||1 Variant||French Canadian|
|Autosomal Recessive Polycystic Kidney Disease||PKHD1||3 Variants||N/A|
|Beta Thalassemia and Related Hemoglobinopathies||HBB||10 Variants||Cypriot, Greek, Italian, Sardinian|
|Bloom Syndrome||BLM||1 Variant||Ashkenazi Jewish|
|Congenital Disorder of Glycosylation Type 1a (PMM2-CDG)||PMM2||2 Variants||Danish|
|Cystic Fibrosis||CFTR||28 Variants||European, Hispanic/Latino, Ashkenazi Jewish|
|D-Bifunctional Protein Deficiency||HSD17B4||2 Variants||N/A|
|Dihydrolipoamide Dehydrogenase Deficiency||DLD||1 Variant||Ashkenazi Jewish|
|Familial Dysautonomia||IKBKAP||1 Variant||Ashkenazi Jewish|
|Fanconi Anemia Group C||FANCC||3 Variants||Ashkenazi Jewish|
|GRACILE Syndrome||BCS1L||1 Variant||Finnish|
|Glycogen Storage Disease Type Ia||G6PC||1 Variant||Ashkenazi Jewish|
|Glycogen Storage Disease Type Ib||SLC37A4||2 Variants||N/A|
|Hereditary Fructose Intolerance||ALDOB||3 Variants||European|
|Leigh Syndrome, French Canadian Type||LRPPRC||1 Variant||French Canadian|
|Limb-Girdle Muscular Dystrophy Type 2D||SGCA||1 Variant||Finnish|
|Limb-Girdle Muscular Dystrophy Type 2E||SGCB||1 Variant||Southern Indiana Amish|
|Limb-Girdle Muscular Dystrophy Type 2I||FKRP||1 Variant||European|
|MCAD Deficiency||ACADM||3 Variants||Northern European|
|Maple Syrup Urine Disease Type 1B||BCKDHB||2 Variants||Ashkenazi Jewish|
|Neuronal Ceroid Lipofuscinosis (CLN5-Related)||CLN5||1 Variant||Finnish|
|Neuronal Ceroid Lipofuscinosis (PPT1-Related)||PPT1||3 Variants||Finnish|
|Niemann-Pick Disease Type A||SMPD1||3 Variants||Ashkenazi Jewish|
|Nijmegen Breakage Syndrome||NBN||1 Variant||Eastern European|
|Nonsyndromic Hearing Loss and Deafness, DFNB1 (GJB2-Related)||GJB2||2 Variants||Ashkenazi Jewish, European|
|Pendred Syndrome and DFNB4 Hearing Loss||SLC26A4||6 Variants||N/A|
|Primary Hyperoxaluria Type 2||GRHPR||1 Variant||European|
|Rhizomelic Chondrodysplasia Punctata Type 1||PEX7||1 Variant||N/A|
|Sickle Cell Anemia||HBB||1 Variant||African|
|Sjögren-Larsson Syndrome||ALDH3A2||1 Variant||Swedish|
|Tay-Sachs Disease||HEXA||4 Variants||Ashkenazi Jewish, Cajun|
|Tyrosinemia Type I||FAH||4 Variants||French Canadian, Finnish|
|Usher Syndrome Type 1F||PCDH15||1 Variant||Ashkenazi Jewish|
|Usher Syndrome Type 3A||CLRN1||1 Variant||Ashkenazi Jewish|
|Zellweger Syndrome Spectrum (PEX1-Related)||PEX1||1 Variant||N/A|
*Our tests can be used to determine carrier status in adults from saliva collected using an FDA-cleared collection device (Oragene·DX model OGD-500.001), but cannot determine if you have two copies of the genetic variant. The tests are not intended to diagnose a disease, or tell you anything about your risk for developing a disease in the future. On their own, carrier status tests are not intended to tell you anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life.
All traits reports
Asparagus Odor Detection
Back Hair (available for men only)
Bald Spot (available for men only)
Bitter Taste Perception
Finger Length Ratio
Light or Dark Hair
Male Hair Loss (available for men only)
Newborn Hair Amount
Photic Sneeze Reflex
Sweet Taste Preference
Toe Length Ratio
*Our tests can be used to determine carrier status in adults from saliva collected using an FDA-cleared collection device (Oragene·DX model OGD-500.001), but cannot determine if you have two copies of the genetic variant. Each test is most relevant for people of certain ethnicities. The tests are not intended to diagnose a disease, or tell you anything about your risk for developing a disease in the future. On their own, carrier status tests are not intended to tell you anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life.
** The Cystic Fibrosis carrier status test is indicated for the detection of 28 variants in the CFTR gene and is most relevant for people of Ashkenazi Jewish, European, and Hispanic/Latino descent. The Sickle Cell Anemia carrier status test is indicated for the detection of the HbS variant in the HBB gene and is most relevant for people of African descent. The carrier status tests related to hereditary hearing loss consist of two tests – one indicated for the detection of two variants in the GJB2 gene which is most relevant for people of Ashkenazi Jewish and European descent, and one indicated for the detection of six variants in the SLC26A4 gene.